Actively Recruiting
Evaluating the Safety and Effectiveness of the Tonbridge Intracranial Stent Compared to Wingspan Stent System for Treating Symptomatic Intracranial Atherosclerotic Stenosis
Led by Ton-Bridge Medical Tech. Co., Ltd · Updated on 2026-01-02
200
Participants Needed
13
Research Sites
47 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of the Intracranial Stent Tonbridge compared to the Wingspan Stent System in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis. This prospective, multicenter, randomized controlled trial is conducted across 13 centers in China with 200 participants who have this condition and meet specific study criteria. Participants will receive either the Intracranial Stent Tonbridge or the Wingspan Stent System to treat narrowed intracranial arteries. The trial aims to determine if the Tonbridge stent is not inferior to the Wingspan stent. Treatments are delivered through endovascular procedures targeting affected large arteries such as the internal carotid, middle cerebral, vertebral, or basilar arteries. During the study, participants will undergo evaluations at multiple time points up to 24 months after the procedure, including assessments of stroke and death rates within 30 days, restenosis rates at 6, 12, and 24 months, and functional outcomes measured by the modified Rankin Scale. Safety will be monitored by tracking adverse events, device success, and stroke incidence. The total study duration spans up to two years with follow-up visits to monitor health and treatment results.
CONDITIONS
Brief Title
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Research Team
L
Long Chen
Y
Yuhan Yan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here